ELISA Kit for Glucagon (GCG)
CEB266MU
Product group Assays
Product CEB266MU is not available
Product not available
There may be an alternative product available, please contact our technical support team.
Overview
- SupplierCloud-Clone Corp.
- Product NameELISA Kit for Glucagon (GCG)
- Delivery Days Customer12
- Assay Detection Range18.52-1,500pg/mL
- Assay PrecisionIntra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Glucagon (GCG) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level ...
- Assay SensitivityThe minimum detectable dose of this kit is typically less than 7.47pg/mL
- Assay Test PrincipleThis assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Glucagon (GCG) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled Glucagon (GCG) ...
- Assay Time2h
- CertificationResearch Use Only
- UNSPSC41116158
References
- Guo X, Cui C, Song J, et al. Mof acetyltransferase inhibition ameliorates glucose intolerance and islet dysfunction of type 2 diabetes via targeting pancreatic α-cells. Mol Cell Endocrinol. 2021,537:111425. doi: 10.1016/j.mce.2021.111425Read this paper
- Qi L, Chen Z, Wang Y, et al. Subcutaneous liraglutide ameliorates methylglyoxal-induced Alzheimer-like tau pathology and cognitive impairment by modulating tau hyperphosphorylation and glycogen synthase kinase-3β. Am J Transl Res. 2017,9(2):247-260.Read this paper
- Xiao N, Lou MD, Lu YT, et al. Ginsenoside Rg5 attenuates hepatic glucagon response via suppression of succinate-associated HIF-1α induction in HFD-fed mice. Diabetologia. 2017,60(6):1084-1093. doi: 10.1007/s00125-017-4238-yRead this paper
- Qi L, Ke L, Liu X, et al. Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model. Eur J Pharmacol. 2016,783:23-32. doi: 10.1016/j.ejphar.2016.04.052Read this paper
- Bang CY, Choung SY. Enzogenol improves diabetes-related metabolic change in C57BL/KsJ-db/db mice, a model of type 2 diabetes mellitus. J Pharm Pharmacol. 2014,66(6):875-85. doi: 10.1111/jphp.12211Read this paper
- Fabrizi M, Marchetti V, Mavilio M, et al. IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity. Diabetes. 2014,63(6):2086-96. doi: 10.2337/db13-0939Read this paper



